Liver cancer, particularly hepatocellular carcinoma (HCC), poses a significant health challenge worldwide, intricately linked to bile acid metabolism disruptions.Recent research unveils how an imbalance in bile acids can not only trigger liver disease but also influence cancer development, shining a spotlight on potential treatment avenues.